Cargando…
Prognostic value of epigenetic markers for canine mast cell cancer
Canine Mast cell tumors (MCTs) constitute approximately 21% of all canine skin tumors. Despite the use of comprehensive grading systems, biological aggressiveness is sometimes difficult to predict, therefore there is a need for better prognostic markers. Progression in various cancers involves DNA h...
Autores principales: | Syed, Shahzar, Knight, Britta J., Wood, Geoffrey A., Coomber, Brenda Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062589/ https://www.ncbi.nlm.nih.gov/pubmed/36996057 http://dx.doi.org/10.1371/journal.pone.0283616 |
Ejemplares similares
-
Beclin-1 is a novel predictive biomarker for canine cutaneous and
subcutaneous mast cell tumors
por: Knight, Britta J., et al.
Publicado: (2021) -
Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours
por: Da Silva, Lucas, et al.
Publicado: (2017) -
Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone
por: Webster, Joshua D, et al.
Publicado: (2008) -
Histological classification and expression of markers of canine mast cell tumors
por: Cruz, V. S., et al.
Publicado: (2020) -
Mast Cells as a Potential Prognostic Marker in Prostate Cancer
por: Taverna, Gianluigi, et al.
Publicado: (2013)